CONCERT PHARMACEUTICALS, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Revenue:
License and research and development revenue
Other revenue (Note 14 and Note 13)
Milestone revenue
Total revenue
Net loss
Other comprehensive income:
Unrealized loss on investments, available for sale
Comprehensive income (loss)
Comprehensive loss

Net loss attributable to common stockholders - basic and diluted
Net loss per share attributable to common stockholders - basic (in dollars per share)
Net loss per share attributable to common stockholders - diluted (in dollars per share)
Weighted-average number of common shares used in net loss per share attributable to common stockholders - basic (in shares)
Weighted-average number of common shares used in net loss per share attributable to common stockholders - diluted (in shares)
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Investment income
Other income
Interest and other expense
Loss on extinguishment of debt (Note 13)
Income (Loss) before income taxes
Unrealized loss on marketable equity securities
Unrealized loss on warrant liabilities (Note 14)
Loss before income taxes
Income tax benefit

Comments